Fosaprepitant

3 trials 1 recruiting AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

5 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Sponsors using this IMP

Helsinn Healthcare S.A. 1 Prinses Maxima Centrum voor Kinderoncologie B.V. 1 Region Vaesternorrland 1 Umea University 1

All trials

3 total

Postoperative recovery with the addition of long-acting NK1- and 5-HT3 receptor antagonists as prophylaxis for post-operative nausea and vom… Pending

2025-522529-36-00 Phase III 1 country Region Vaesternorrland; Umea University
An open-label, pharmacokinetic, safety, and efficacy study (Part I, single cycle) and double-blind, efficacy, non inferiority, and safety st… Recruiting

2024-514321-39-00 Phase II/III 3 countries Helsinn Healthcare S.A.
DAVINCY trial: optimal Duration of (fos)Aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind p… Ended

2024-517846-32-00 Phase III 1 country Prinses Maxima Centrum voor Kinderoncologie B.V.

Showing 1–3 of 3 trials

← All drugs A–Z